Total studies | Studies reporting both “positive” results and null results | |||
---|---|---|---|---|
Number of “Positive” studies | Likelihood ratio | |||
80% Power, 5% alpha | 45% Power, 25% alpha | |||
All studies | 16 | 7 | 218.07+ | 3.76+ |
Symptom duration | 13 | 4 | 18.78− | 1.55− |
Return to play | 7 | 2 | 9.45− | 1.46− |
Lowest risk for biasa | 7 | 4 | 611.5+ | 4.14+ |